HBM Healthcare Investments AG
Invests in a diversified portfolio of innovative private and public healthcare companies.
HBMN | SW
Overview
Corporate Details
- ISIN(s):
- CH0012627250 (+2 more)
- LEI:
- 549300IFDFSDRT4D3076
- Country:
- Switzerland
- Address:
- Bundesplatz 1, 6300 Zug
- Website:
- https://www.hbmhealthcare.com/en
- Sector:
- Financial and insurance activities
- Industry:
- Activities of trusts, funds and similar financial entities
Description
HBM Healthcare Investments AG is a global investment company specializing in the healthcare sector. It offers investors access to a diversified portfolio comprising both private and public companies, with an emphasis on emerging and later-stage firms. The company's investment strategy focuses on innovative businesses within biotechnology, medical technology, diagnostics, and pharmaceuticals. Utilizing a fundamental, bottom-up selection process, the firm constructs a balanced portfolio of venture capital, private equity, and listed equity holdings to capture value from medical advancements and innovation.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-01 17:49 |
Earnings Release
HBM Healthcare Investments reports strong quarterly results NAV rises by 16.4 …
|
English | 2.9 KB | ||
| 2025-10-01 02:00 |
Earnings Release
HBM Healthcare Investments reports strong quarterly results – NAV rises by 16.4…
|
English | 4.5 KB | ||
| 2025-10-01 02:00 |
Earnings Release
HBM Healthcare Investments erzielt ein starkes Quartalsergebnis – NAV steigt im…
|
German | 4.9 KB | ||
| 2025-10-01 02:00 |
Earnings Release
Key Figures
30.09.2025
|
English | 12.9 KB | ||
| 2025-09-29 10:34 |
M&A Activity
Genmab to Acquire HBM Portfolio Company Merus for USD 8 billion in Cash
|
English | 2.4 KB | ||
| 2025-09-29 02:00 |
M&A Activity
Genmab to Acquire HBM Portfolio Company Merus for USD 8 billion in Cash
|
English | 3.9 KB | ||
| 2025-09-29 02:00 |
M&A Activity
Genmab übernimmt HBM-Portfoliounternehmen Merus für USD 8 Milliarden in bar
|
German | 4.2 KB | ||
| 2025-09-16 17:47 |
Earnings Release
Key Figures
15.09.2025
|
English | 8.8 KB | ||
| 2025-09-16 02:00 |
Net Asset Value
Key Figures
15.09.2025
|
English | 12.9 KB | ||
| 2025-09-10 08:35 |
M&A Activity
HBM Portfolio Company Swixx BioPharma and Lundbeck Sign Multi-Regional CNS Part…
|
English | 4.4 KB | ||
| 2025-09-10 02:00 |
M&A Activity
HBM Portfolio Company Swixx BioPharma and Lundbeck Sign Multi-Regional CNS Part…
|
English | 6.1 KB | ||
| 2025-09-10 02:00 |
M&A Activity
HBM-Portfoliounternehmen Swixx BioPharma und Lundbeck unterzeichnen multiregion…
|
German | 6.7 KB | ||
| 2025-09-01 17:47 |
Earnings Release
Key Figures
31.08.2025
|
English | 8.8 KB | ||
| 2025-08-18 17:47 |
Earnings Release
Key Figures
15.08.2025
|
English | 8.8 KB | ||
| 2025-08-18 02:00 |
Earnings Release
Key Figures
15.08.2025
|
English | 12.9 KB |
Automate Your Workflow. Get a real-time feed of all HBM Healthcare Investments AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for HBM Healthcare Investments AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-22 | N/A | Non-Executive member | Sell | None | 34,860.00 CHF |
| 2025-04-03 | N/A | Non-Executive member | Sell | None | 110,217.50 CHF |
| 2025-04-01 | N/A | Non-Executive member | Buy | None | 140,010.00 CHF |
| 2025-04-01 | N/A | Non-Executive member | Buy | None | 100,007.50 CHF |
| 2024-12-19 | N/A | Non-Executive member | Buy | None | 53,760.00 CHF |
| 2024-12-17 | N/A | Non-Executive member | Buy | None | 48,256.00 CHF |
| 2024-11-06 | N/A | Executive member | Buy | None | 91,123.80 CHF |
| 2024-07-02 | N/A | Non-Executive member | Buy | None | 49,200.00 CHF |
| 2024-06-04 | N/A | Executive member | Sell | None | 52,750.00 CHF |
| 2024-04-03 | N/A | Non-Executive member | Buy | None | 139,944.05 CHF |
